The EU is implementing new regulations to hold companies liable for human rights and environmental violations within the global supply chain. On 24 April 2024, the European Parliament passed the Corporate Sustainability Due...more
Unternehmen haften künftig auch zivilrechtlich nach europäischen Vorgaben für Menschenrechts- und Umweltverletzungen entlang globaler Lieferketten. Am 24. April 2024 hat das Europäische Parlament die Corporate Sustainability...more
The IoT sector has exploded over the past few years, and, even taking into account the globally inhibitive effects of COVID-19, this growth shows few long-term signs of abating. The buoyant, fast-paced IoT industry was the...more
2/12/2021
/ Coronavirus/COVID-19 ,
Cybersecurity ,
Data Protection ,
EU ,
Hackers ,
Infectious Diseases ,
Internet of Things ,
Life Sciences ,
Manufacturers ,
Popular ,
Risk Mitigation ,
Supply Chain ,
Telehealth
We're excited to bring you issue 77 of our "International products law review" with insights and updates on all aspects of products law. In this issue, provide updates on COVID-19, address promoting the circular economy...more
6/1/2020
/ Consumer Product Companies ,
Coronavirus/COVID-19 ,
Department of Health and Human Services (HHS) ,
Drones ,
EU ,
Medical Devices ,
Public Readiness and Emergency Preparedness Act (PREP Act) ,
Safety Standards ,
Smart Devices ,
Soda Tax ,
Supply Chain ,
Tax Planning
The spread of COVID-19 is causing Europe to experience one of the greatest health crises in decades, the consequences of which are still unpredictable. Faced with this unprecedented situation, the governments of different...more
5/16/2020
/ Coronavirus/COVID-19 ,
EU ,
France ,
Germany ,
Goods or Services ,
Italy ,
Legislative Agendas ,
Life Sciences ,
Medical Devices ,
Medical Supplies ,
Personal Protective Equipment ,
Pharmaceutical Industry ,
Spain ,
Supply Chain
The spread of COVID-19 is causing Europe to experience one of the greatest health crises in decades, the consequences of which are still unpredictable. Faced with this unprecedented situation, the governments of different...more
4/1/2020
/ Business Interruption ,
Coronavirus/COVID-19 ,
Emergency Management Plans ,
France ,
Germany ,
Italy ,
Life Sciences ,
Medical Supplies ,
Spain ,
Suppliers ,
Supply Chain
In the wake of combatting the COVID-19 pandemic, the German Federal Government is proposing to enable further measures on federal level. The proposal includes important measures concerning supply of medical devices,...more
We are pleased to provide you with the third annual installment of our Life Sciences and Health Care Horizons guide. For each of these guides, we have asked our industry thought leaders throughout the world to write about...more
2/26/2020
/ 3D Printing ,
AIDS ,
Analytics ,
Artificial Intelligence ,
Biosimilars ,
Biotechnology ,
Blockchain ,
California Consumer Privacy Act (CCPA) ,
Cyber Threats ,
Cybersecurity ,
Data Breach ,
Department of Defense (DOD) ,
Digital Health ,
Drug Distribution ,
Drug Pricing ,
EU ,
Federal Funding ,
Food and Drug Administration (FDA) ,
General Data Protection Regulation (GDPR) ,
Health Technology ,
HIV ,
Incident Response Plans ,
Intellectual Property Protection ,
Life Sciences ,
Medical Device Data System ,
Medical Devices ,
Medical Software ,
Over The Counter Drugs (OTC) ,
Pharmaceutical Industry ,
PHI ,
Prescription Drugs ,
Procurement Guidelines ,
Regulatory Standards ,
Research and Development ,
Right to Try ,
Robotics ,
Supply Chain ,
Telehealth
Germany should not be a blank spot on your company map. Located at the center of Continental Europe, it is the world’s fourth biggest economy and the home of some of the biggest companies in the world. It plays a key role in...more
10/22/2019
/ Antitrust Provisions ,
Arbitration ,
Class Action ,
Competition ,
Cross-Border Transactions ,
Customs ,
Data Privacy ,
Doing Business ,
EU ,
Exports ,
Germany ,
Imports ,
Intellectual Property Protection ,
Mass Tort Litigation ,
Supply Chain ,
Tariffs
Innovation in the life sciences and health care industries is occurring at a dizzying pace. Five years ago, anti-PD-1 antibodies from Merck and BMS had yet to be approved, CAR-T therapies were still in small-scale clinical...more
3/18/2019
/ Artificial Intelligence ,
Asia ,
Biologics ,
Biotechnology ,
Data Breach ,
Digital Health ,
Information Technology ,
Life Sciences ,
Pharmaceutical Industry ,
Prescription Drugs ,
Supply Chain
Innovation in the life sciences and health care industries is occurring at a dizzying pace. Five years ago, anti-PD-1 antibodies from Merck and BMS had yet to be approved, CAR-T therapies were still in small-scale clinical...more
4/4/2018
/ 3D Printing ,
Acquisitions ,
Artificial Intelligence ,
Biologics ,
Biosimilars ,
Biotechnology ,
Blockchain ,
Cyber Attacks ,
Cybersecurity ,
Data Breach ,
Digital Health ,
Distributed Ledger Technology (DLT) ,
Drug Pricing ,
Emerging Markets ,
EU ,
General Data Protection Regulation (GDPR) ,
Generic Drugs ,
Innovation ,
Life Sciences ,
Medical Reimbursement ,
Mergers ,
Over The Counter Derivatives (OTC) ,
Pharmaceutical Industry ,
Prescription Drugs ,
Private Equity ,
Regulatory Oversight ,
Supply Chain ,
Transfer Pricing ,
UK Brexit ,
Yates Memorandum